CHANGES IN NEO- AND ADJUVANT TREATMENT OF BREAST CANCER IN THE LAST 5 YEARS
Authors: M.B. Stenina, M.A. Frolova, D.Z. Kupchan, S.A. Tjulandin
DOI: https://www.doi.org/10.31917/1803256
Neo- and adjuvant therapy is an integral component of complex therapy of breast cancer, that brings a considerable contribution to successful treatment of this pathology. Guidelines on treatment of early-stage breast cancer are a subject of regular, not less than 1–2 times per a year, reassessment procedure, considering the latest results of fundamental and clinical oncology researches. The current review examines results of the key investigations devoted to early-stage breast cancer treatment and highlights changes to recommendations on neo- and adjuvant therapy, that were made during the
last 5 years on the basis of these considerations.